Healthcare is the tape, but it is not one trade
Five of the ten strongest clusters in our thematic map are healthcare: life science tools & diagnostics 6th of 97, gene & cell therapy 7th, oncology biotech 8th, managed care 9th, large-cap pharma 10th. Ten of the top nineteen. No other sector comes close.
Two weeks ago I wrote that the tape and the sell-side disagreed: tools were 2nd on price and 96th on analyst upside. That gap is closing — from the analyst side. On three-month target revisions, managed care now ranks 4th of 100 clusters, tools 6th, healthcare providers 9th, healthcare IT 10th. The consensus is chasing.